AI Medicine: Big Pharma Investing Billions, But Success Is Debatable

Major pharmaceutical companies are committing billions of dollars to integrate artificial intelligence into drug discovery and development processes. While the industry aims to accelerate medical breakthroughs, the actual efficacy and clinical success of these AI-driven initiatives remain unproven.